{
    "id": 30927,
    "fullName": "SOX2 T116D",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "SOX2 T116D does not lie within any known functional domains of the Sox2 protein (UniProt.org). T116D maintains Ssr2 responsiveness in a reporter assay (PMID: 29401647), results in a loss of Ubr5c-mediated ubiquitination of Sox2, promotes tumor sphere formation in cell culture, and is resistant to Akt inihibition (PMID: 30894683).",
            "references": [
                {
                    "id": 16192,
                    "pubMedId": 30894683,
                    "title": "AKT drives SOX2 overexpression and cancer cell stemness in esophageal cancer by protecting SOX2 from UBR5-mediated degradation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30894683"
                },
                {
                    "id": 16193,
                    "pubMedId": 29401647,
                    "title": "Phosphorylation of Sox2 at Threonine 116 is a Potential Marker to Identify a Subset of Breast Cancer Cells with High Tumorigenecity and Stem-Like Features.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29401647"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 6657,
        "geneSymbol": "SOX2",
        "terms": [
            "SOX2",
            "ANOP3",
            "MCOPS3"
        ]
    },
    "variant": "T116D",
    "createDate": "09/10/2019",
    "updateDate": "12/20/2019",
    "referenceTranscriptCoordinates": {
        "id": 182484,
        "transcript": "NM_003106",
        "gDna": "chr3:g.181712706_181712707delACinsGA",
        "cDna": "c.346_347delACinsGA",
        "protein": "p.T116D",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19616,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, esophageal squamous cell carcinoma cells expressing SOX2 T116D were insensitive to MK2206-induced degradation of Sox2 and inhibition of tumor sphere formation in culture (PMID: 30894683).",
            "molecularProfile": {
                "id": 33218,
                "profileName": "SOX2 T116D"
            },
            "therapy": {
                "id": 816,
                "therapyName": "MK2206",
                "synonyms": null
            },
            "indication": {
                "id": 3748,
                "name": "esophagus squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 16192,
                    "pubMedId": 30894683,
                    "title": "AKT drives SOX2 overexpression and cancer cell stemness in esophageal cancer by protecting SOX2 from UBR5-mediated degradation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30894683"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 33218,
            "profileName": "SOX2 T116D",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 182484,
            "transcript": "NM_003106",
            "gDna": "chr3:g.181712706_181712707delACinsGA",
            "cDna": "c.346_347delACinsGA",
            "protein": "p.T116D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}